XCaliber Health Secures $6.5 Million to Scale Agentic OS for Healthcare Workflow Automation

New updates have been reported about XCaliber Health.

XCaliber Health has raised $6.5 million in seed financing to accelerate development and nationwide deployment of its agentic operating system, positioning the company to replace manual, fragmented workflows across health systems, provider groups, and digital health organizations with semi-autonomous execution. The round was led by ManchesterStory with participation from Benhamou Global Ventures and Arka Venture Labs, and funds will support product expansion that connects EHRs, billing, scheduling, and other tools into a single coordination layer aimed at cutting administrative costs and improving care delivery.

The platform already processes over eight million chart updates and generates more than 160,000 EHR updates daily for more than 700,000 patients, with prebuilt agents handling use cases such as interoperability, analytics, scheduling, prescription refills, and care gap management. By automating tasks that currently consume an estimated 15.5 staff hours per physician per week—such as record retrieval, prior authorization, and referrals—XCaliber targets material savings for practices that can exceed $1.4 million annually for a 20‑provider group, while maintaining human oversight through a structured human‑in‑the‑loop model and configurable degrees of autonomy.

XCaliber’s core differentiation lies in unifying siloed data into a single intelligence layer that delivers practice‑specific insights, orchestrates work across all clinical and operational systems in real time, and supports varying levels of autonomy for operational versus clinical workflows. Leadership describes the vision as enabling healthcare organizations to operate as semi‑autonomous enterprises, where agents manage routine tasks like follow‑up scheduling and refill processing end‑to‑end, staff intervene only when needed, and clinicians regain time for direct patient care.

The new capital strengthens XCaliber’s ability to scale beyond early adopters and deepen market penetration at a time when providers are looking to rationalize point solutions and realize measurable ROI from AI investments. Investors highlight that XCaliber is already demonstrating production‑level adoption rather than pilot‑stage experimentation, suggesting a clearer path to revenue growth as health systems seek platforms that can coordinate disparate technologies and reduce operational waste. Executives and stakeholders should view this financing as both validation of XCaliber’s model and a catalyst for further commercial expansion and product enhancement in the healthcare automation space.